863
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Associating Gene Therapy with the Human Genome Project

Pages 77-97 | Received 31 May 2009, Accepted 07 May 2010, Published online: 01 Oct 2020

References

  • Anderson W. F. (1992). Human gene therapy. Science, 256, 808–813.
  • Anderson W. F. (2002). The current status of clinical gene therapy. Human Gene Therapy, 13(11), 1261–1262.
  • Anon (1997). (Gene therapy: can it be a good example of clinical medicine?). Scias, 2(9), 56–60.
  • Aono Y. (2000). (What is the gene problem?). Tokyo: Shin'yosha.
  • Bush V. (1945). Science: The endless frontier. Washington: United States Government Printing Office.
  • Cantor C. R. (1990). Orchestrating the human genome project. Science, 248, 49–51.
  • Cavazzana-Calvo M. (2000). Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science, 288, 669–672.
  • Cohen D. (1999). (Genes of hope: The Human Genome Project and gene therapy). Tokyo: Kosakusha. Translation of Cohen (1993) Les genes de l'espoir. Paris: Robert Laffont.
  • Collins H. M. Evans R. (2002). The third wave of science studies: Studies of expertise and experience. Social Studies of Science, 32(2), 235–296.
  • Conrad P. Gabe J. (Eds.). (1999). Sociological perspectives on the new genetics. Oxford: Blackwell.
  • Council for International Organizations of Medical Sciences (CIOMS) (1990). The Declaration of Inuyama. http://www.cioms.ch/frame_1990_texts_of_guidelines.htm
  • DNA Mondai Kenkyukai (1994). (Gene therapy). Tokyo: Shakai hyoronsha.
  • Emilien G. (2000). Impact of genomics on drug discovery and clinical medicine. QJM: Monthly journal of the Association of Physicians, 93(7), 391–423.
  • Eurotransplant International Foundation (2009). Annual Report 2008. http://www.eurotransplant.org/files/annual_report/ar_2008.pdf
  • Friedmann T. (1986). (Gene therapy: A giant step or a small step). Tokyo: Shujunsha. Translation of Friedmann (1983) Gene therapy: Fact and fiction in biology's new approaches to disease. Cold Spring Harbor Laboratory Press.
  • Fukami T. (1996). (Gene therapy of cancer). Tokyo: Kodansha.
  • Fukumoto E. (1987). (The age of gene therapy). Gijutsu to ningen 技術と人間 (Technology and Human Beings), 16(9), 115–127.
  • Fukumoto E. (1988). (Gene therapy and eugenic policy). Gijutsu to ningen 技術と人間 (Technology and Human Beings), 17(3), 10–13.
  • Fukumoto E. (2002). (Slippery slope to the capitalization of human body). Tokyo: Gendai shokan.
  • General Administrative Agency of the Cabinet (1986). The Public Survey on Lifescience . http://www8.cao.go.jp/survey/s60/S60-12-60-14.html
  • Grobstein C. Flower M. (1984). Gene therapy: Proceed with caution. The Hastings Center Report, 14 (2), 13–17.
  • Hacein-Bey-Abina S. (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science, 302, 415–419.
  • Hattori S. (2005). (From complete decoding of human genome to the understanding of human beings). Tokyo: Toyoshoten.
  • Hayashi M. (2002). (Manipulating life: Social construction of biological science and technology). Tokyo: NTT publishing.
  • Hayashi M. (2003). (What does “successful” mean in advanced medicine? An example of Japanese gene therapy applied to ADA deficiency). Kagaku Gijutsu Shakairon Kenkyu 科学技術社会論研究 (Journal of Science and Technology Studies), 2, 57–67.
  • Hayashi M. (2004). (Whose misunderstanding of gene?). In Kuwako T. (Ed.), Inochi no Rinrigaku いのちの倫理学 (Ethics of life) (pp. 190–208). Tokyo: Corona Publishing.
  • Heath D. Rapp R. Taussig K.-S. (2004). Genetic citizenship. In Nugent D. Vincent J. (Eds.), A companion to the anthropology of politics (pp. 152–167). Malden: Blackwell.
  • Irwin A. (2001). Constructing the scientific citizen: Science and democracy in the biosciences. Public Understanding of Science, 10(1), 1–18.
  • Irwin A. Wynne B. (1996). Misunderstanding science? The public reconstruction of science and technology. Cambridge: Cambridge University Press.
  • Ishiyama I. (2008). Relationship between public attitudes toward genomic studies related to medicine and their level of genomic literacy in Japan. American Journal of Medical Genetics. Part A, 13, 1696–1706.
  • Isono N. (1981). (Gene “therapy” that concerns you). Kagaku asahi 科学朝日 (Scientific Asahi), 1, 32–34.
  • Itakura M. Moritani M. (2000). (Medicine in the age of “genome science”). Kagaku (Science Journal), 70(4), 312–317.
  • Juengst E. T. (1991). The human genome project and bioethics. Kennedy Institute of Ethics Journal, 1, 71–74.
  • Kaiser J. (2003). Gene therapy: Seeking the cause of induced leukemias in X-SCID trials. Science, 299, 495.
  • Kato H. (Ed.). (1996). (Studies on points of contact of human genome research with society). Kyoto: Kyoto Daigaku Rinrigaku Kenkyu-shitsu.
  • Kayukawa J. (2010). (Power that permeates stem cells: Human beings in biocapitalism). Tokyo: Meiji Gakuin University. Ph.D. diss.
  • Kobayashi T. (2004). (Who considers science and technology policy?). Nagoya: Nagoya University Press.
  • Lock M. (2002). Twice dead: Organ transplants and the reinvention of death. Berkeley: University of California Press.
  • Lyon J. Gorner P. (1998). (The birth of gene therapy: Here started the dramas which startle the world). Translation of Lyon & Gorner (1995) Altered fates: Gene therapy and the retooling of human life. New York: Norton.
  • Magill G. (2001). Ethical Perspectives on Mapping The Human Genome. Health Care Ethics USA, 9(1), http://chce.slu.edu/hceusa/1_2001_1.html
  • Marshall E. (1995). Gene therapy's growing pains. Science, 269, 1050–1055.
  • Matsubara Y. (2007). (genes, patients and citizens) In Tsuge A. Kato S. (eds.), Idenshi gijutsu no shakaigaku 遺伝子技術の社会学 (Studies of technosociety; Sociology of genomics). Tokyo: Bunka shobo hakubunsha. 63-77.
  • McKie R. (1992). (The Front Line of Gene Therapy). Translation of McKie (1988) The genetic jigsaw: The story of the new genetics. New York: Oxford University Press.
  • Mori K. (2001). (The age of remodeling human beings). Tokyo: Kodansha.
  • Motohashi N. (2002). (Human genome and gene therapy). Tokyo: Maruzen.
  • Murray T. H. (1990). Human gene therapy, the public, and public policy. Human Gene Therapy, 1, 49–54.
  • Nakahara H. (2001). (Overview of human genome). Tokyo: PHP publishing.
  • Nakamura Y. Nakamura M. (2001). (The genome century: Socioeconomic change in the era of biotechnology). Tokyo: Kodansha.
  • National Institute of Science and Technology Policy (2001). (The 2001 Survey of Public Attitudes Toward and Understanding of Science & Technology in Japan). http://www.nistep.go.jp/achiev/ftx/jpn/rep072j/pdf/rep072j.pdf
  • Nelkin D. Lindee M. S. (1995). The DNA mystique: The gene as cultural icon. New York: Freeman.
  • Nichols E. K. (1992). (What is gene therapy? Challenging fatal diseases). Tokyo: Kodansha. Translation of Nichols(1988) Human gene therapy. Cambridge, MA: Harvard University Press.
  • Nudeshima J. (1995). (Principle is needed in the ethics of advanced medicine). Asahi Shimbun, April 21, 1995.
  • Nukaga Y. (2008). The President's commission and somatic cell gene therapy: An analysis of regulatory science in the United States. Seibutsugakushi kenkyu 生物学史研究 (The Japanese Journal of the History of Biology), 80, 1–16.
  • Office of Technology Assessment (1988). Mapping our genes: Genome projects: How big? How fast?
  • Ogiwara T. Morishita R. (2001). (Genes save lives: Cardiovascular disease and gene therapy). Suita: Osaka University Press.
  • Onodera M. (1998). Successful peripheral T-lymphocyte-directed gene transfer for a patient with severe combined immune deficiency caused by adenosine deaminase deficiency. Blood, 1, 30–36.
  • Ozawa K. (1994). (Gene therapy to treat cancers and incurable diseases). Tokyo: Houken.
  • President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research (1982). Splicing life: A report on the social and ethical issues of genetic engineering with human beings.
  • Rose N. Novas C. (2004). Biological citizenship. In Ong A. Collier S. J. (Eds.), Global assemblages: Technology, politics, and ethics as anthropological problems (pp. 439–463). Oxford: Blackwell.
  • Sakaki Y. (1995). (Human genome: The goal of the human genome project). Tokyo: Iwanami shoten.
  • Sakaki Y. (2001). (Human genome: From decoding to application and understanding of people). Tokyo: Iwanami shoten
  • Sakiyama Y. Ariga T. (2001). (Gene therapy for immune deficiency). In Tani S. Asano S. (Eds.), Idenshi-chiryo no shintenkai 遺伝子治療の新展開 (New development of gene therapy) (pp. 75–85). Tokyo: Yodosha.
  • Santilli G. Thornhill S. I. Kinnon C. Thrasher A. J. (2008). Gene therapy of inherited immunodeficiencies. Expert Opinion on Biological Therapy, 8(4), 397–407.
  • Savill J. (1997). Science, medicine, and the future: Molecular genetic approaches to understanding disease. British Medical Journal, 314, 126–129.
  • Shapiro R. (1993). (Reading the human blueprint, genome). Tokyo: Kodansha. Translation of Shapiro (1991) The human blueprint: The race to unlock the secrets of our genetic script. New York: St. Martin's.
  • Shimizu N. (2000). (Japanese front runner Shimizu Nobuyoshi talks on the truth and falsehood of the human genome project). Tokyo: Bizinesu-sha.
  • Shimizu N. (2001). (Reading the human genome, the blueprint of life). Tokyo: Iwanami shoten.
  • Stockdale A. (1999a). Waiting for the cure: Mapping the social relations of human gene therapy research. Sociology of Health & Illness, 21(5), 579–596.
  • Stockdale A. (1999b). Public understanding of genetics and Alzheimer disease. Genetic Testing, 3(1), 139–145.
  • Takaku F. (1994). Foreword. In Ozawa ( 1994) 1–2.
  • Terakado K. (2000). (Breakthrough of gene therapy: French team's world first success for inborn immune deficiency). Newton, 20(7), 8–15.
  • Thompson L. (1995). (Gene therapy revolution: Footsteps of the scientists who fought against genes). Translation of Thompson. (1994). Correcting the code: Inventing the genetic for the human body. New York: Simon & Schuster.
  • Tsuge A. (1999). (Reproductive technology as culture: Discourse analysis of doctors who are involved with fertility treatment). Kyoto: Shoraisha.
  • Watson J. D. (1990). The human genome project: Past, present, and future. Science, 248, 44–49.
  • Yamaguchi H. (1989). (Gene therapy putting into practical use). Zaikai Kansoku 財界観測 (Observation of business world)., 5, 72–75.
  • Yonemoto S. (1982). (Gene manipulation and human rights: Test-tube baby and gene therapy). Gijutsu to ningen 技術と人間 (Technology and Human Beings), 11(7), 12–27.
  • Yonemoto S. (1985). (Bioethics). Tokyo: Kodansha.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.